RZB — Reinsurance Group of America, Incorporated stock price, charts and financials
QT60Reinsurance Group of America, IncorporatedReinsurance Group of America, Incorporated (NYSE: RZB) is a Financial Services company in the Insurance - Life industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | - | P/E | 1.38 | EPS (ttm) | 18.34 | Insider Own | 0.10% | Shs Outstand | 504.45M | Perf Week | 0.08% |
| Market Cap | 12.78B | Forward P/E | 0.88 | EPS next Y | 28.73 | Insider Trans | - | Shs Float | 502.78M | Perf Month | 0.32% |
| Enterprise Value | 13.89B | PEG | 0.13 | EPS next Q | - | Inst Own | - | Short Float | - | Perf Quarter | 1.32% |
| Income | 1.23B | P/S | 0.66 | EPS this Y | 42.94% | Inst Trans | - | Short Ratio | - | Perf Half Y | 2.01% |
| Sales | 19.50B | P/B | 0.96 | EPS next Y | 9.58% | ROA | 0.75% | Short Interest | - | Perf YTD | 2.10% |
| Book/sh | 26.53 | P/C | 0.11 | EPS next 5Y | 10.94% | ROE | 9.48% | 52W High | 25.38 -0.16% | Perf Year | 2.59% |
| Cash/sh | 222.66 | P/FCF | 2.31 | EPS past 3/5Y | 32.30% 22.90% | ROIC | 7.44% | 52W Low | 24.50 3.43% | Perf 3Y | 1.32% |
| Dividend Est. | 1.44 (5.67%) | EV/EBITDA | 22.57 | Sales past 3/5Y | 13.48% 10.18% | Gross Margin | 32.62% | Volatility | 0.05% 0.12% | Perf 5Y | -9.66% |
| Dividend TTM | 1.44 (5.67%) | EV/Sales | 0.71 | EPS Y/Y TTM | 70.92% | Oper. Margin | 41.63% | ATR (14) | 0.04 | Perf 10Y | - |
| Dividend Ex-Date | Jun 01, 2026 | Quick Ratio | 35.30 | Sales Y/Y TTM | -11.78% | Profit Margin | 6.29% | RSI (14) | 64.33 | Recom | 2.44 |
| Dividend Gr. 3/5Y | 0.00% 0.00% | Current Ratio | 35.30 | EPS Q/Q | 17.56% | SMA20 | 0.17% | Beta | 0.34 | Target Price | - |
| Payout | 19.72% | Debt/Eq | 0.42 | Sales Q/Q | -79.65% | SMA50 | 0.47% | Rel Volume | 0.00 | Prev Close | 25.34 |
| Employees | 4,300 | LT Debt/Eq | 0.42 | Earnings | Apr 30 | SMA200 | 1.20% | Avg Volume | 115.22K | Price | 25.34 |
| IPO Date | Jun 13, 2016 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -16.62% -83.30% | Net Debt/EBITDA | 1.81 | Volume | 0 | Change | 0.00% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Jun-22-23 | Downgrade | Jefferies | Buy → Hold | |
| Jun-07-23 | Downgrade | Raymond James | Strong Buy → Buy | |
| Mar-14-23 | Upgrade | Citigroup | Sell → Buy | |
| Jan-04-23 | Upgrade | Evercore ISI Group | In Line → Outperform | |
| Dec-05-22 | Upgrade | RBC Capital | Sector Perform → Outperform | |
| Oct-30-22 | Downgrade | JP Morgan | Overweight → Neutral | |
| Jun-01-22 | Upgrade | Credit Suisse | Underperform → Neutral | |
| May-18-22 | Upgrade | Morgan Stanley | Underweight → Equal Weight | |
| Oct-11-21 | Upgrade | Keefe, Bruyette & Woods | Market Perform → Outperform | |
| Jul-11-21 | Upgrade | JP Morgan | Neutral → Overweight |
Reinsurance Group of America, Inc. is a holding company, which engages in the provision of traditional and non-traditional life and health reinsurance products. It operates through the following segments: U.S. and Latin America, Canada, Europe, Middle East, and Africa, Asia Pacific, and Corporate and Other. The U.S. and Latin America segment markets individual and group life and health reinsurance to domestic clients for a variety of products through yearly renewable term agreements, coinsurance, and modified coinsurance. The Canada segment offers individual life reinsurance, and, to a lesser extent, creditor, group life and health, critical illness, and disability reinsurance, through yearly renewable term and coinsurance agreements. The Europe, Middle East, and Africa segment serves individual and group life and health products through yearly renewable term and coinsurance agreements, reinsurance of critical illness coverage that provides a benefit in the event of the diagnosis of a pre-defined critical illness, and underwritten annuities. The Asia Pacific segment consists of individual and group life and health reinsurance, critical illness coverage, disability, and superannuation through yearly renewable term and coinsurance agreements. The Corporate and Other segment consists of investment income from unallocated invested assets, investment related gains, and losses and service fees. The company was founded in 1973 and is headquartered in Chesterfield, MO.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 19,503 | 23,698 | 22,107 | 18,567 | 16,217 | 16,651 | 14,592 | 14,301 | 12,876 | |
| Cost of Goods Sold Incl. D&A | 13,173 | 17,003 | 16,903 | 13,872 | 11,982 | 12,776 | 816 | 868 | 1 | |
| Gross Profit | 6,361 | 6,703 | 5,259 | 4,705 | 4,235 | 3,875 | 13,776 | 13,433 | 12,875 | |
| Selling, General and Administrative Excl. Other | 0 | 0 | 0 | 0 | 45 | 55 | 12 | 39 | 30 | |
| Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Other Operating Expense | 4,125 | 5,163 | 4,279 | 3,545 | 3,472 | 3,129 | 2,065 | 2,033 | 2,079 | |
| Operating Income | 8,120 | 1,540 | 980 | 1,160 | 718 | 691 | 740 | 1,334 | 1,023 | |
| Interest Expense | 284 | 366 | 315 | 257 | 191 | 132 | 183 | 203 | 0 | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -7,729 | 366 | 315 | 257 | 191 | 132 | -4 | 1 | -177 | |
| Net Income Before Taxes | 106 | 1,540 | 980 | 1,160 | 718 | 691 | 553 | 1,132 | 846 | |
| Income Taxes | -1,126 | 351 | 256 | 251 | 197 | 74 | 138 | 262 | 130 | |
| Consolidated Net Income | 1,227 | 1,182 | 717 | 902 | 517 | 617 | 415 | 870 | 716 | |
| Net Income From Continuing Operations | 1,232 | 1,189 | 724 | 909 | 521 | 617 | 415 | 870 | 716 | |
| Net Income | 1,227 | 1,182 | 717 | 902 | 517 | 617 | 415 | 870 | 716 | |
| EPS (Recurring) | 18.63 | 17.94 | 10.90 | 13.60 | 7.73 | 9.10 | 6.35 | 13.88 | 11.25 | |
| EPS (Basic, Before Extraordinaries) | 18.63 | 17.94 | 10.90 | 13.60 | 7.73 | 9.10 | 6.35 | 13.88 | 11.25 | |
| EPS (Diluted) | 18.34 | 17.69 | 10.73 | 13.44 | 7.64 | 9.03 | 6.31 | 13.88 | 11.00 | |
| EBITDA | 616 | 2 | 1,295 | 1,806 | 947 | 823 | 785 | 1,384 | 1,068 | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 1.38 | 1.40 | 2.29 | 1.88 | 3.03 | 3.25 | 4.58 | 2.03 | 2.14 | |
| Price To Sales Ratio | 0.09 | 0.07 | 0.07 | 0.09 | 0.10 | 0.12 | 0.13 | 0.12 | 0.12 | |
| Gross Margin | 32.62 | 28.29 | 23.79 | 25.34 | 26.11 | 23.27 | 94.41 | 93.93 | 99.99 | |
| Operating Margin | 41.63 | 6.50 | 4.43 | 6.25 | 4.43 | 4.15 | 5.07 | 9.33 | 7.95 | |
| Net Margin | 6.29 | 4.99 | 3.24 | 4.86 | 3.19 | 3.71 | 2.84 | 6.08 | 5.56 | |
| Shares Outstanding | 66 | 66 | 66 | 67 | 67 | 68 | 65 | 63 | 64 | |
| Market Capitalization | 1,672 | 1,638 | 1,623 | 1,694 | 1,549 | 1,994 | 1,880 | 1,775 | 1,507 | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| HUTTON WILLIAM L | EVP, General Counsel & Secy. | Feb 15 '24 | Sale | 171.83 | 1,588 | 272,866 | 13,625 | Feb 20 |
| PORTER JONATHAN | EVP, Global Chief Risk Officer | Feb 07 '24 | Option Exercise | 90.06 | 2,790 | 251,267 | 7,524 | Feb 09 |
| Wainwright Simon | EVP, Head of EMEA | Feb 07 '24 | Option Exercise | 78.48 | 3,429 | 269,108 | 9,367 | Feb 09 |
| BARBI LESLIE | EVP, Chief Investment Officer | Jan 18 '24 | Option Exercise | 0.00 | 1,560 | 0 | 3,738 | Jan 22 |
| CHENG TONY KIN SHUN | President | Jan 18 '24 | Option Exercise | 0.00 | 945 | 0 | 21,083 | Jan 22 |
| Hayden John W. | EVP, Controller | Jan 18 '24 | Option Exercise | 0.00 | 503 | 0 | 15,985 | Jan 22 |
| HERRMANN RONALD | EVP | Jan 18 '24 | Option Exercise | 0.00 | 1,395 | 0 | 1,835 | Jan 22 |
| LARSON TODD C | SEVP, Chief Financial Officer | Jan 18 '24 | Option Exercise | 0.00 | 2,375 | 0 | 46,051 | Jan 22 |
| Ozeki Arthur | EVP, Head of Asia Pacific | Jan 18 '24 | Option Exercise | 0.00 | 459 | 0 | 3,930 | Jan 22 |
| PORTER JONATHAN | EVP, Global Chief Risk Officer | Jan 18 '24 | Option Exercise | 0.00 | 660 | 0 | 6,477 | Jan 22 |
| Wainwright Simon | EVP, Head of EMEA | Jan 18 '24 | Option Exercise | 0.00 | 469 | 0 | 7,910 | Jan 22 |
| HUTTON WILLIAM L | EVP, General Counsel & Secy. | Jan 18 '24 | Option Exercise | 0.00 | 780 | 0 | 14,405 | Jan 22 |
| HERRMANN RONALD | EVP | Dec 13 '23 | Buy | 166.78 | 440 | 73,383 | 440 | Dec 15 |
| HERRMANN RONALD | EVP | Nov 10 '23 | Sale | 161.05 | 510 | 82,136 | 0 | Nov 14 |
| CARSON LAWRENCE S | EVP, GFS | Nov 10 '23 | Option Exercise | 127.35 | 16,084 | 2,048,263 | 18,942 | Nov 13 |